Skip to content

Detection of hEad Pulse for Ischemic StrOke Verification Study

EPISODE-VS: hEad Pulse for Ischemic StrOke Verification Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05602740
Acronym
EPISODE_VS
Enrollment
500
Registered
2022-11-02
Start date
2023-06-15
Completion date
2023-10-01
Last updated
2023-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Brief summary

Prehospital providers encounter patients with suspected stroke frequently. Prehospital providers need tools to help triage large vessel stroke patients to comprehensive stroke centers. This device will identify large vessel stroke to ultimately improve triage decisions and optimize outcomes.

Detailed description

Patients suspected of stroke by a prehospital provider will have a headset placed to record their headpulse during the encounter. These measurements will be used to assess the accuracy of the device at predicting the presence of large vessel occlusion (LVO) stroke. The MindRhythm, Inc., Harmony® 5000 device is intended to be used in the pre-hospital setting by medical professionals to diagnose large vessel occlusion stroke in adults suspected of having a stroke.

Interventions

DEVICEHarmony

Passive recording of the head pulse

Sponsors

Wayne State University
CollaboratorOTHER
MindRhythm, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

• suspected stroke in the prehospital setting

Exclusion criteria

* scalp laceration * Patient refusal * Prisoner, other vulnerable population * Prehospital provider feels that the recording may interfere with care

Design outcomes

Primary

MeasureTime frameDescription
The primary effectiveness objective is to estimate the sensitivity and specificity of LVO diagnosis with Harmony®.Through study completion, an average of 6 monthsThe subject's final discharge diagnosis based on the CTA scan and the neurologist's assessment will serve as the ground truth diagnosis. The sensitivity and specificity will be estimated as the point estimate (Harmony® identified correctly divided by the ground truth number); the confidence intervals will be estimated by the Clopper-Pearson method (exact intervals for proportions).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026